Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BehavioralCare/PSSNY CareLine compliance program for homebound to debut in New York in November.

Executive Summary

NEW YORK CARELINE PHARMACY COMPLIANCE INTERVENTION PROGRAM, run by the Irvine, Calif.-based firm BehavioralCare and the Pharmacists Society of the State of New York, has secured commitments from insurers and unions to participate beginning in November. The CareLine program, "a proactive telephone-based reminder, verification, support and reporting service," focuses on homebound but ambulatory patients who otherwise would be consigned to nursing home and long-term care facilities. The cost of the program is about $350 per patient per month, a fraction of the cost of institutional care, according to CareLine materials.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel